These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 10656346)

  • 21. Tackling antibiotic resistance a priority.
    Nurs Stand; 2014 Nov; 29(11):10. PubMed ID: 25388698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of antibiotic utilization on a urological ward with antibiotic policy.
    Casewell M
    Prog Clin Biol Res; 1979; 35():171-9. PubMed ID: 119974
    [No Abstract]   [Full Text] [Related]  

  • 23. Can antibiotic resistance be controlled?
    Murray BE
    N Engl J Med; 1994 Apr; 330(17):1229-30. PubMed ID: 8139634
    [No Abstract]   [Full Text] [Related]  

  • 24. Hospital antibiotic stewardship.
    Lesprit P; Brun-Buisson C
    Curr Opin Infect Dis; 2008 Aug; 21(4):344-9. PubMed ID: 18594284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vancomycin use in a university medical center: comparison with hospital infection control practices advisory committee guidelines.
    Beidas S; Khamesian M
    Infect Control Hosp Epidemiol; 1996 Dec; 17(12):773-4. PubMed ID: 8985761
    [No Abstract]   [Full Text] [Related]  

  • 26. Methodology of prevention of antibiotic resistance.
    Shetty A
    J Assoc Physicians India; 2010 Dec; 58 Suppl():47-8. PubMed ID: 21568010
    [No Abstract]   [Full Text] [Related]  

  • 27. Managing antibiotic use--impact of infection control.
    Wenzel RP; Wong MT
    Clin Infect Dis; 1999 May; 28(5):1126-7. PubMed ID: 10452646
    [No Abstract]   [Full Text] [Related]  

  • 28. Rational use of antibiotics in the intensive care unit: impact on microbial resistance and costs.
    Geissler A; Gerbeaux P; Granier I; Blanc P; Facon K; Durand-Gasselin J
    Intensive Care Med; 2003 Jan; 29(1):49-54. PubMed ID: 12528022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic restriction policy paradoxically increased private drug consumptions outside Taiwan's National Health Insurance.
    Kuo SC; Shih SM; Hsieh LY; Lauderdale TY; Chen YC; Hsiung CA; Chang SC
    J Antimicrob Chemother; 2017 May; 72(5):1544-1545. PubMed ID: 28175312
    [No Abstract]   [Full Text] [Related]  

  • 30. An audit of teicoplanin use in a district general hospital.
    Seetulsingh P; Collier S
    J Hosp Infect; 2006 Oct; 64(2):194-6. PubMed ID: 16831490
    [No Abstract]   [Full Text] [Related]  

  • 31. [Programs for optimizing the use of antibiotics (PROA) in Spanish hospitals: GEIH-SEIMC, SEFH and SEMPSPH consensus document].
    Rodríguez-Baño J; Paño-Pardo JR; Alvarez-Rocha L; Asensio Á; Calbo E; Cercenado E; Cisneros JM; Cobo J; Delgado O; Garnacho-Montero J; Grau S; Horcajada JP; Hornero A; Murillas-Angoiti J; Oliver A; Padilla B; Pasquau J; Pujol M; Ruiz-Garbajosa P; San Juan R; Sierra R; ; ;
    Farm Hosp; 2012; 36(1):33.e1-30. PubMed ID: 22137161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implementation problems of decision support system for nosocomial infection.
    Rems M; Bohanec M; Urh B; Kramar Z
    Stud Health Technol Inform; 1997; 43 Pt A():358-62. PubMed ID: 10179572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Setting standards--antibiotic policies.
    Gerken A
    J Hosp Infect; 1993 Aug; 24(4):309-11. PubMed ID: 8104990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-term effect of antibiotic control policy on the usage patterns and cost of antimicrobials, mortality, nosocomial infection rates and antibacterial resistance.
    Arda B; Sipahi OR; Yamazhan T; Tasbakan M; Pullukcu H; Tunger A; Buke C; Ulusoy S
    J Infect; 2007 Jul; 55(1):41-8. PubMed ID: 17512598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of antibiotic resistance and its audit in our country: how to develop an antibiotic policy.
    Wattal C
    Indian J Med Microbiol; 2012; 30(4):381-3. PubMed ID: 23183459
    [No Abstract]   [Full Text] [Related]  

  • 36. Impact of a hospital-wide programme of heterogeneous antibiotic use on the development of antibiotic-resistant Gram-negative bacteria.
    Takesue Y; Nakajima K; Ichiki K; Ishihara M; Wada Y; Takahashi Y; Tsuchida T; Ikeuchi H
    J Hosp Infect; 2010 May; 75(1):28-32. PubMed ID: 20346536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaginal & rectal carriage of Streptococcus agalactiae in the Czech Republic: incidence, serotypes distribution & susceptibility to antibiotics.
    Motlová J; Straková L; Urbásková P; Sak P; Sever T
    Indian J Med Res; 2004 May; 119 Suppl():84-7. PubMed ID: 15232169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical results and costs due to improved antibiotics policies].
    Gyssens IC; Kullberg BJ; van der Meer JW
    Ned Tijdschr Geneeskd; 1999 Nov; 143(47):2361-4. PubMed ID: 10590774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibiotic streamlining: monitoring and compliance.
    Norvell M
    Pharm Pract Manag Q; 1996 Jul; 16(2):41-51. PubMed ID: 10161611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bold approach curbs antibiotic use for bronchitis.
    Healthc Demand Dis Manag; 2000 May; 6(5):65-70. PubMed ID: 11383015
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.